Literature DB >> 30142373

Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.

Jeannette J Yu1, Elvira Agrón1, Traci E Clemons2, Amitha Domalpally3, Freekje van Asten4, Tiarnan D Keenan1, Catherine Cukras1, Emily Y Chew5.   

Abstract

PURPOSE: To investigate the natural history and genetic associations of drusenoid pigment epithelial detachment (DPED) associated with age-related macular degeneration (AMD).
DESIGN: Retrospective analysis of a prospective cohort study. PARTICIPANTS: Of the 4203 Age-Related Eye Disease Study 2 (AREDS2) participants, 391 eyes (325 participants) had DPED without late AMD at the time of DPED detection. Genetic analyses included 120 white AREDS2 participants and 145 Age-Related Eye Disease Study (AREDS) participants with DPED.
METHODS: Baseline and annual stereoscopic fundus photographs were graded centrally to detect DPED, a well-defined yellow elevated mound of confluent drusen ≥433 μm in diameter, and to evaluate progression rates to late AMD: geographic atrophy (GA) and neovascular (NV)-AMD. Five single nucleotide polymorphisms (CFH [rs10611670], C3 [rs2230199], CFI [rs10033900], C2/CFB [rs114254831], ARMS2 [rs10490924]) and genetic risk score (GRS) group were investigated for association with DPED development. Kaplan-Meier analyses and multivariable proportional hazard regressions were performed. MAIN OUTCOME MEASURES: Progression rates to late AMD and decrease of ≥3 lines in visual acuity (VA) from the time of DPED detection; association of rate of DPED development with genotype.
RESULTS: Mean (standard deviation [SD]) follow-up time from DPED detection was 4.7 (0.9) years. DPED was associated with increased risk of progression to late AMD (hazard ratio [HR], 2.36; 95% confidence interval [CI], 1.98-2.82; P < 0.001); 67% of eyes progressed to late AMD 5 years after DPED detection. Drusenoid pigment epithelial detachment was associated with increased risk of ≥3 lines of VA loss (HR, 3.08; CI, 2.41-3.93; P < 0.001) with 46% of eyes experiencing vision loss at 5 years (with or without progression to late AMD). ARMS2 risk alleles (1 vs. 0: HR, 2.72, CI, 1.58-4.70; 2 vs. 0: HR, 3.16, CI, 1.60-6.21, P < 0.001) and increasing GRS group (4 vs. 1) (HR, 12.17, CI, 3.66-40.45, P < 0.001) were significantly associated with DPED development in AREDS. There were no significant genetic results in AREDS2.
CONCLUSIONS: This study replicates the results of previous natural history studies of eyes with DPED including the high rates of progression to late AMD and vision loss (regardless of progression to late AMD). The genetic associations are consistent with genes associated with AMD progression. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30142373      PMCID: PMC6348044          DOI: 10.1016/j.ophtha.2018.08.017

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  29 in total

1.  The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.

Authors: 
Journal:  Control Clin Trials       Date:  1999-12

2.  Classification of retinal pigment epithelial detachments associated with drusen.

Authors:  M E Hartnett; J J Weiter; A Garsd; A E Jalkh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Retinal pigment epithelial detachments in the elderly: classification and outcome.

Authors:  A G Casswell; D Kohen; A C Bird
Journal:  Br J Ophthalmol       Date:  1985-06       Impact factor: 4.638

4.  Evolution of soft drusen in age-related macular degeneration.

Authors:  J P Sarks; S H Sarks; M C Killingsworth
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

5.  Evolution of geographic atrophy of the retinal pigment epithelium.

Authors:  J P Sarks; S H Sarks; M C Killingsworth
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

6.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

7.  Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration.

Authors:  Yanling Ouyang; Florian M Heussen; Amirhossein Hariri; Pearse A Keane; SriniVas R Sadda
Journal:  Ophthalmology       Date:  2013-07-04       Impact factor: 12.079

8.  Causes of blind certifications in England and Wales: April 1999-March 2000.

Authors:  C Bunce; R Wormald
Journal:  Eye (Lond)       Date:  2007-03-02       Impact factor: 3.775

9.  Causes and prevalence of visual impairment among adults in the United States.

Authors:  Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2004-04

10.  A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.

Authors:  Lars G Fritsche; Wilmar Igl; Jessica N Cooke Bailey; Felix Grassmann; Sebanti Sengupta; Jennifer L Bragg-Gresham; Kathryn P Burdon; Scott J Hebbring; Cindy Wen; Mathias Gorski; Ivana K Kim; David Cho; Donald Zack; Eric Souied; Hendrik P N Scholl; Elisa Bala; Kristine E Lee; David J Hunter; Rebecca J Sardell; Paul Mitchell; Joanna E Merriam; Valentina Cipriani; Joshua D Hoffman; Tina Schick; Yara T E Lechanteur; Robyn H Guymer; Matthew P Johnson; Yingda Jiang; Chloe M Stanton; Gabriëlle H S Buitendijk; Xiaowei Zhan; Alan M Kwong; Alexis Boleda; Matthew Brooks; Linn Gieser; Rinki Ratnapriya; Kari E Branham; Johanna R Foerster; John R Heckenlively; Mohammad I Othman; Brendan J Vote; Helena Hai Liang; Emmanuelle Souzeau; Ian L McAllister; Timothy Isaacs; Janette Hall; Stewart Lake; David A Mackey; Ian J Constable; Jamie E Craig; Terrie E Kitchner; Zhenglin Yang; Zhiguang Su; Hongrong Luo; Daniel Chen; Hong Ouyang; Ken Flagg; Danni Lin; Guanping Mao; Henry Ferreyra; Klaus Stark; Claudia N von Strachwitz; Armin Wolf; Caroline Brandl; Guenther Rudolph; Matthias Olden; Margaux A Morrison; Denise J Morgan; Matthew Schu; Jeeyun Ahn; Giuliana Silvestri; Evangelia E Tsironi; Kyu Hyung Park; Lindsay A Farrer; Anton Orlin; Alexander Brucker; Mingyao Li; Christine A Curcio; Saddek Mohand-Saïd; José-Alain Sahel; Isabelle Audo; Mustapha Benchaboune; Angela J Cree; Christina A Rennie; Srinivas V Goverdhan; Michelle Grunin; Shira Hagbi-Levi; Peter Campochiaro; Nicholas Katsanis; Frank G Holz; Frédéric Blond; Hélène Blanché; Jean-François Deleuze; Robert P Igo; Barbara Truitt; Neal S Peachey; Stacy M Meuer; Chelsea E Myers; Emily L Moore; Ronald Klein; Michael A Hauser; Eric A Postel; Monique D Courtenay; Stephen G Schwartz; Jaclyn L Kovach; William K Scott; Gerald Liew; Ava G Tan; Bamini Gopinath; John C Merriam; R Theodore Smith; Jane C Khan; Humma Shahid; Anthony T Moore; J Allie McGrath; Reneé Laux; Milam A Brantley; Anita Agarwal; Lebriz Ersoy; Albert Caramoy; Thomas Langmann; Nicole T M Saksens; Eiko K de Jong; Carel B Hoyng; Melinda S Cain; Andrea J Richardson; Tammy M Martin; John Blangero; Daniel E Weeks; Bal Dhillon; Cornelia M van Duijn; Kimberly F Doheny; Jane Romm; Caroline C W Klaver; Caroline Hayward; Michael B Gorin; Michael L Klein; Paul N Baird; Anneke I den Hollander; Sascha Fauser; John R W Yates; Rando Allikmets; Jie Jin Wang; Debra A Schaumberg; Barbara E K Klein; Stephanie A Hagstrom; Itay Chowers; Andrew J Lotery; Thierry Léveillard; Kang Zhang; Murray H Brilliant; Alex W Hewitt; Anand Swaroop; Emily Y Chew; Margaret A Pericak-Vance; Margaret DeAngelis; Dwight Stambolian; Jonathan L Haines; Sudha K Iyengar; Bernhard H F Weber; Gonçalo R Abecasis; Iris M Heid
Journal:  Nat Genet       Date:  2015-12-21       Impact factor: 38.330

View more
  8 in total

1.  Biomarkers for Nonexudative Age-Related Macular Degeneration and Relevance for Clinical Trials: A Systematic Review.

Authors:  Vivienne Fang; Maria Gomez-Caraballo; Eleonora M Lad
Journal:  Mol Diagn Ther       Date:  2021-08-25       Impact factor: 4.074

2.  Blue-light fundus autofluorescence imaging of pigment epithelial detachments.

Authors:  Almut Bindewald-Wittich; Joanna Dolar-Szczasny; Sandrine H Kuenzel; Leon von der Emde; Maximilian Pfau; Robert Rejdak; Steffen Schmitz-Valckenberg; Thomas Ach; Jens Dreyhaupt; Frank G Holz
Journal:  Eye (Lond)       Date:  2022-05-17       Impact factor: 3.775

3.  Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study.

Authors:  Zhen Huang; Kai-Yu Deng; Yu-Meng Deng; Yan-Nian Hui; Yan-Ping Song
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

4.  Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration: 24-month outcomes.

Authors:  Hyeong Min Kim; Na-Kyung Ryoo; Kyu Hyung Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-21       Impact factor: 3.535

5.  Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment.

Authors:  Taiyo Shijo; Yoichi Sakurada; Koji Tanaka; Akiko Miki; Atsushi Sugiyama; Hajime Onoe; Aya Chubachi; Wataru Kikushima; Yu Wakatsuki; Seigo Yoneyama; Ryusaburo Mori; Kenji Kashiwagi
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

6.  Surgical Treatment for a Full-Thickness Macular Hole That Developed on a Large Drusenoid Pigment Epithelial Detachment.

Authors:  Kunihiro Azuma; Tomoyasu Shiraya; Fumiyuki Araki; Satoshi Kato; Shigeko Yashiro; Miyuki Nagahara; Takashi Ueta
Journal:  Cureus       Date:  2021-06-20

7.  Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration.

Authors:  Min Seok Kim; Na-Kyung Ryoo; Kyu Hyung Park
Journal:  Sci Rep       Date:  2020-09-01       Impact factor: 4.379

8.  Sodium-Iodate Injection Can Replicate Retinal Degenerative Disease Stages in Pigmented Mice and Rats: Non-Invasive Follow-Up Using OCT and ERG.

Authors:  Céline Koster; Koen T van den Hurk; Jacoline B Ten Brink; Colby F Lewallen; Boris V Stanzel; Kapil Bharti; Arthur A Bergen
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.